Mark R. Hughes
Wayne State University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Mark R. Hughes.
Journal of Clinical Investigation | 2002
Ana O. Hoff; Philip Catala-Lehnen; Pamela M. Thomas; Matthias Priemel; Johannes M. Rueger; Igor Nasonkin; Allan Bradley; Mark R. Hughes; Nelson G. Ordonez; Gilbert J. Cote; Michael Amling; Robert F. Gagel
Calcitonin (CT) is a known inhibitor of bone resorption. Calcitonin gene-related peptide-alpha (CGRPalpha), produced by alternative RNA processing of the CT/CGRP gene, has no clearly defined role in bone. To better understand the physiologic role of the CT/CGRP gene we created a mouse in which the coding sequences for both CT and CGRPalpha were deleted by homologous recombination. The CT/CGRP(-/-) knockout (KO) mice procreated normally, there were no identifiable developmental defects at birth, and they had normal baseline calcium-related chemistry values. However, KO animals were more responsive to exogenous human parathyroid hormone as evidenced by a greater increase of the serum calcium concentration and urine deoxypyridinoline crosslinks, an effect reversed by CT and mediated by a greater increase in bone resorption than in controls. Surprisingly, KO mice have significantly greater trabecular bone volume and a 1.5- to 2-fold increase in bone formation at 1 and 3 months of age. This effect appears to be mediated by increased bone formation. In addition, KO mice maintain bone mass following ovariectomy, whereas wild-type mice lose approximately one-third of their bone mass over 2 months. These findings argue for dual roles for CT/CGRP gene products: prevention of bone resorption in hypercalcemic states and a regulatory role in bone formation.
Genome Biology | 2001
John C. Rockett; J. Christopher Luft; J Brian Garges; Stephen A. Krawetz; Mark R. Hughes; Kwan Hee Kirn; Asa J. Oudes; David J. Dix
BackgroundOver the past five years, interest in and use of DNA array technology has increased dramatically, and there has been a surge in demand for different types of arrays. Although manufacturers offer a number of pre-made arrays, these are generally of utilitarian design and often cannot accommodate the specific requirements of focused research, such as a particular set of genes from a particular tissue. We found that suppliers did not provide an array to suit our particular interest in testicular toxicology, and therefore elected to design and produce our own.ResultsWe describe the procedures used by members of the US Environmental Protection Agency MicroArray Consortium (EPAMAC) to produce a mouse testis expression array on both filter and glass-slide formats. The approaches used in the selection and assembly of a pertinent, nonredundant list of testis-expressed genes are detailed. Hybridization of the filter arrays with normal and bromochloroacetic acid-treated mouse testicular RNAs demonstrated that all the selected genes on the array were expressed in mouse testes.ConclusionWe have assembled two lists of mouse (950) and human (960) genes expressed in the mouse and/or human adult testis, essentially all of which are available as sequence-verified clones from public sources. Of these, 764 are homologous and will therefore enable close comparison of gene expression between murine models and human clinical testicular samples.
Cancer | 2005
Isaac J. Powell; Susan Land; Jyotirmoy Dey; Lance K. Heilbrun; Mark R. Hughes; Wael Sakr; Richard Everson
The authors examined the impact of the number of CAG repeats in exon 1 of the androgen receptor on disease progression among men with prostate carcinoma after prostatectomy. This polymorphism has been associated with alterations in activity of the androgen receptor in in vitro systems and with the risk of clinically diagnosed prostate carcinoma in some epidemiologic studies. An earlier series found that, among men at low risk of progressive disease, a small number of CAG repeats predicted a high risk of recurrence, and the impact of CAG repeats varied among men with different risks of progressive disease.
Cytogenetic and Genome Research | 2001
Christine J. Ye; W. Lu; Guo Liu; Steven W. Bremer; Y. A. Wang; Peter B. Moens; Mark R. Hughes; Stephen A. Krawetz; Henry H.Q. Heng
Spectral karyotyping (SKY) represents an effective tool to detect individual chromosomes and analyze major karyotype abnormalities within an entire genome. We have tested the feasibility of combining SKY and FISH/protein detection in order to combine SKY’s unique abilities with specific loci detection. Our experimental results demonstrate that various combined protocols involving SKY, FISH and immunostaining work well when proper procedures are used. This combined approach allows the tracking of key genes or targeted chromosome regions while monitoring changes throughout the whole genome. It is particularly useful when simultaneously monitoring the behavior of both protein complexes and DNA loci within the genome. The details of this methodology are described and systematically tested in this communication.
Prenatal Diagnosis | 1999
Pierre F. Ray; Joyce C. Harper; Asangla Ao; Deborah M. Taylor; Robert M.L. Winston; Mark R. Hughes; Alan H. Handyside
Lesch–Nyhan syndrome (LN) is a severe X‐linked recessive disorder caused by a deficiency of the enzyme hypoxanthine phosphoribosyl transferase (HPRT). Clinical features displayed by affected boys are particularly severe and disturbing and include hyperuricaemia, characteristic neurological features including self‐mutilation, choreothetosis, spasticity and mental retardation. A couple with an boy diagnosed with LN and a history of pregnancy termination was referred to the Hammersmith Hospital. Their affected son was born in 1982 after an uncomplicated pregnancy and vaginal delivery. Eight subsequent pregnancies had been unsuccessful. There were five therapeutic terminations and three spontaneous abortions, one at least directly caused by the sampling procedure during amniocentesis. From 1989 to 1991 two unsuccessful preimplantation genetic diagnosis (PGD) cycles by sexing were performed by DNA amplification. The mutation was characterized and a nested PCR protocol was designed which allowed the efficient amplification of the affected loci followed by the detection of the mutant allele by restriction digestion. Three PGD cycles were performed using this specific diagnostic test before a successful pregnancy was achieved resulting in the birth of a healthy unaffected baby girl. Copyright
Cytogenetic and Genome Research | 2000
Guo Liu; W. Lu; Steven W. Bremer; H. Hameister; B. Schreiner; Mark R. Hughes; Henry H.Q. Heng
We have evaluated the mouse cell line WMP2 using both GTG-banding analysis and spectral karyotyping to verify the reliability of using this established cell line derived from WMP/WMP mice. The WMP cell lines contain easily identifiable metacentric fusion chromosomes and are used extensively for gene mapping. Because of karyotypical changes in the WMP1 cell line, WMP2 was examined. Our results demonstrate that WMP2 is stable during culture, and the karyotype is simple and easy to use. Based on the findings discussed in this paper, we recommend the use of the WMP2 cell line for future prospective gene mapping in the mouse.
The Prostate | 2004
Heinric Williams; Isaac J. Powell; Susan Land; Wael Sakr; Mark R. Hughes; Nimesh P. Patel; Lance K. Heilbrun; Richard Everson
Genomics | 2000
Rhonda H. Nicholson; Serafino Pantano; James F. Eliason; Anne Galy; Sarah Weiler; Joseph Kaplan; Mark R. Hughes; Minoru S.H. Ko
Genome | 2001
Henry H.Q. Heng; Guo Liu; Wei Lu; Steve Bremer; Christine J. Ye; Mark R. Hughes; Peter B. Moens
Fertility and Sterility | 2007
A.P. Goud; P.T. Goud; Michael P. Diamond; Bernard Gonik; D.I Dozortsev; Mark R. Hughes